Aquila can help you understand the immunomodulatory effects of your drug candidates within the tumour microenvironment and/or in combination with other immune modulators, efficiently progressing your route to clinic.
We have extensive in vitro immunology, pre-clinical immuno-oncology, RNA sequencing and specialist multiplex histology experience. Our suite of available immuno-oncology services and assays can be specifically tailored to your project:
- PBMC and T Cell Stimulation Assays
- Exhausted T Cell Assays
- Killing Assays
- Phagocytosis Assays
- Myeloid Cell Assays
- Suppression Assays
Please get in touch to discuss how Aquila can help you with your immuno-oncology, immunology, RNA sequencing or specialist histology research needs.